Küsters-Vandevelde, H. V., Willemsen, A. E., Groenen, P. J., Küsters, B., Lammens, M., Wesseling, P., . . . Blokx, W. A. (2014). Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. BioMed Central.
Chicago Stili AlıntıKüsters-Vandevelde, Heidi VN, et al. Experimental Treatment of NRAS-mutated Neurocutaneous Melanocytosis With MEK162, a MEK-inhibitor. BioMed Central, 2014.
MLA AlıntıKüsters-Vandevelde, Heidi VN, et al. Experimental Treatment of NRAS-mutated Neurocutaneous Melanocytosis With MEK162, a MEK-inhibitor. BioMed Central, 2014.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..